Persistent Asymptomatic Proteinuria

Overview of Persistent Asymptomatic Proteinuria

The discovery of proteinuria in an asymptomatic child on a routine non-first-morning urine specimen is a relatively common finding, occurring in 5% to 15% of children.
However, persistent proteinuria, defined by abnormal protein excretion on repeated testing over a minimum of a 2-week period, is much less common and requires systematic evaluation.
Asymptomatic implies the absence of clinical features such as gross hematuria, peripheral edema, hypertension, or apparent kidney dysfunction.
The primary challenge for the clinician is to differentiate benign conditions, such as orthostatic proteinuria, from persistent, fixed proteinuria that heralds an underlying glomerular or tubulointerstitial disorder.

Type of Proteinuria	Pathophysiology and Clinical Characteristics	Common Etiologies
Orthostatic (Postural) Proteinuria	The most common cause of persistent proteinuria in school-aged children and adolescents (up to 60% of cases). Protein excretion is normal when supine but increases up to 10-fold (rarely exceeding 1 g/day) in the upright position.	Unknown exact etiology; possibly related to altered renal hemodynamics, left renal vein compression (nutcracker phenomenon) in the upright position, or an exaggerated response to upright posture in thin individuals.
Fixed Glomerular Proteinuria	Occurs due to the disruption of the glomerular capillary wall (e.g., loss of negative charge or structural podocyte defects), leading to the leakage of large-molecular-weight proteins like albumin.	Minimal change disease, focal segmental glomerulosclerosis (FSGS), membranous nephropathy, IgA nephropathy, diabetic nephropathy, and early Alport syndrome.
Fixed Tubular Proteinuria	Results from injury to the proximal tubules, which impairs their capacity to reabsorb filtered low-molecular-weight (LMW) proteins like $β 2$ -microglobulin and retinol-binding protein.	Inherited disorders (Dent disease, cystinosis, Lowe syndrome) and acquired conditions (tubulointerstitial nephritis, drug toxicity from aminoglycosides or heavy metals).

The essential first step is the collection of a first-morning urine sample to rule out orthostatic proteinuria.
The child must empty the bladder completely before going to bed and collect the very first voided specimen upon awakening.
A negative or trace reading on a dipstick, or a urine protein-to-creatinine ratio (PCR) of $< 0.2$ mg/mg on a first-morning sample collected on 3 consecutive days, definitively confirms orthostatic proteinuria.
If the first-morning urine consistently demonstrates a dipstick reading of $\geq 1 +$ (with specific gravity $> 1.015$ ) or a urine PCR of $\geq 0.2$ mg/mg, the patient has fixed proteinuria and requires a comprehensive nephrological workup.

A meticulous history should screen for recent infectious illnesses, drug exposure (e.g., NSAIDs, antibiotics), and a family history of deafness, visual defects, or end-stage kidney disease.
Physical examination requires accurate assessment of blood pressure, growth percentiles, and screening for subtle signs of systemic diseases, such as purpuric rashes or arthritis.
Urinalysis and phase-contrast microscopy are critical to evaluate for dysmorphic red blood cells, RBC casts (indicating glomerular injury), or white blood cell casts (suggesting tubulointerstitial disease).
If tubular proteinuria is suspected (e.g., male child with isolated proteinuria without hematuria), specific quantification of urinary LMW proteins ( $β 2$ -microglobulin) should be requested.
Blood investigations must include serum urea, creatinine (to calculate estimated GFR), electrolytes, total protein, and serum albumin to detect occult hypoproteinemia.
A tiered immunological evaluation includes serum complements (C3, C4), antinuclear antibodies (ANA), anti-double-stranded DNA, and antistreptolysin O (ASO) titers if a secondary glomerulonephritis is suspected.
Renal ultrasonography is routinely performed to evaluate kidney size, detect structural anomalies, or identify echogenicity changes indicating chronic parenchymal disease.

A kidney biopsy provides a definitive histopathological diagnosis but is not immediately required for every child with asymptomatic, low-grade proteinuria.
Biopsy is strongly indicated if the persistent proteinuria is heavy (urine PCR $> 0.5$ g/g or $> 1$ g/1.73m²/day).
Biopsy is also mandatory if fixed proteinuria of any degree is accompanied by “red flag” clinical features, including:
- Persistent microscopic or macroscopic hematuria.
- Reduced estimated glomerular filtration rate (eGFR).
- Sustained hypertension or the development of peripheral edema/hypoalbuminemia.
- Persistently low serum complement (C3) lasting beyond 12 weeks.
- Systemic features suggestive of lupus nephritis or IgA vasculitis.

Orthostatic Proteinuria: This is recognized as a benign condition. No specific therapeutic intervention is necessary, but the family should be reassured. Annual long-term monitoring for the emergence of non-orthostatic proteinuria, hematuria, or hypertension is advised.
Low-Grade Fixed Proteinuria: Asymptomatic patients with low-grade fixed proteinuria (urine PCR between 0.2 and 1.0 mg/mg) and normal renal function, without hematuria, may be managed with close surveillance. They should undergo periodic assessments of blood pressure, urinalysis, and serum creatinine every 4 to 6 months.
Significant Proteinuria: In patients with persistent, significant glomerular proteinuria, treatment centers on renin-angiotensin-aldosterone system (RAAS) blockade using Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin II Receptor Blockers (ARBs). These agents exert a renoprotective effect by lowering intraglomerular pressure and significantly reducing protein excretion.
Strict dietary sodium restriction is advised to optimize the antiproteinuric efficacy of ACE inhibitors and help maintain normal blood pressure.
If a specific underlying glomerulonephritis is identified via biopsy, targeted immunosuppressive therapy may be instituted based on the exact histopathology and disease severity.